Michael R. Galambos
Advanced in Cholangitis

Dr. Michael R. Galambos

Gastroenterology | Hepatology
Piedmont Healthcare
Digestive Healthcare Of Georgia - Atlanta Suite 4085
95 Collier Rd NW, Suite 4085, 
Atlanta, GA 
Accepting New Patients
Offers Telehealth
Advanced in Cholangitis
Piedmont Healthcare
Digestive Healthcare Of Georgia - Atlanta Suite 4085
95 Collier Rd NW, Suite 4085, 
Atlanta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Galambos is a Hepatologist and a Gastroenterologist in Atlanta, Georgia. Dr. Galambos is rated as an Advanced provider by MediFind in the treatment of Cholangitis. His top areas of expertise are Primary Biliary Cholangitis, Cirrhosis, Enlarged Liver, Endoscopy, and Colonoscopy. Dr. Galambos is currently accepting new patients.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Cholangitis.

Graduate Institution
Emory University School Of Medicine, 1984
Residency
University of Washington Affiliated Hospitals, 1987
Specialties
Gastroenterology
Hepatology
Licenses
Internal Medicine in GA
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine - Gastroenterology
Fellowships
Emory University School of Medicine, 1989
Hospital Affiliations
Piedmont Mountainside Hospital Inc
Northside Hospital Cherokee
Piedmont Hospital, Inc
Union General Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

Digestive Healthcare of Georgia - Atlanta Suite 4085
95 Collier Rd NW, Suite 4085, Atlanta, GA 30309
Call: 404-355-3200

Additional Areas of Focus

Dr. Galambos has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 15, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
Enrollment Status: Terminated
Publish Date: December 15, 2025
Intervention Type: Drug
Study Drug: Belapectin
Study Phase: Phase 2/Phase 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: November 24, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Enrollment Status: Completed
Publish Date: August 11, 2025
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
Enrollment Status: Completed
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: August 02, 2022
Intervention Type: Drug
Study Phase: Phase 3
View 9 Less Clinical Trials

3 Total Publications

Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.
Journal: Alimentary pharmacology & therapeutics
Published: July 28, 2023
View All 3 Publications
Similar Doctors
Advanced in Cholangitis
Dr. Devina Bhasin
Hepatology
Advanced in Cholangitis
Dr. Devina Bhasin
Hepatology

Piedmont Providers LLC

1984 Peachtree Rd Nw, Suite 300, 
Atlanta, GA 
 (3.1 miles away)
404-367-3210
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Devina Bhasin is a Hepatologist in Atlanta, Georgia. Dr. Bhasin is rated as a Distinguished provider by MediFind in the treatment of Cholangitis. Her top areas of expertise are Hepatitis, Visceromegaly, Liver Failure, and Nonalcoholic Steatohepatitis (NASH).

Advanced in Cholangitis
Dr. Rahul Maheshwari
Hepatology
Advanced in Cholangitis
Dr. Rahul Maheshwari
Hepatology

Piedmont Providers LLC

1984 Peachtree Rd Nw, Suite 300, 
Atlanta, GA 
 (3.1 miles away)
404-367-3210
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rahul Maheshwari is a Hepatologist in Atlanta, Georgia. Dr. Maheshwari is rated as a Distinguished provider by MediFind in the treatment of Cholangitis. His top areas of expertise are Jaundice, Hepatitis, Liver Failure, Endoscopy, and Colonoscopy.

Advanced in Cholangitis
Dr. Parita Patel
Hepatology
Advanced in Cholangitis
Dr. Parita Patel
Hepatology

Piedmont Providers LLC

1968 Peachtree Nw Rd, 
Atlanta, GA 
 (3.2 miles away)
404-605-5000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Parita Patel is a Hepatologist in Atlanta, Georgia. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Cholangitis. Her top areas of expertise are Alcoholic Cirrhosis, Ascites, Hepatitis, and Liver Failure.

VIEW MORE CHOLANGITIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Galambos's expertise for a condition
ConditionClose
    • Distinguished
    • Alcoholic Cirrhosis
      Dr. Galambos is
      Distinguished
      . Learn about Alcoholic Cirrhosis.
      See more Alcoholic Cirrhosis experts
    • Ascites
      Dr. Galambos is
      Distinguished
      . Learn about Ascites.
      See more Ascites experts
    • Cirrhosis
      Dr. Galambos is
      Distinguished
      . Learn about Cirrhosis.
      See more Cirrhosis experts
    • Enlarged Liver
      Dr. Galambos is
      Distinguished
      . Learn about Enlarged Liver.
      See more Enlarged Liver experts
    • Hepatitis
      Dr. Galambos is
      Distinguished
      . Learn about Hepatitis.
      See more Hepatitis experts
    • Macroamylasemia
      Dr. Galambos is
      Distinguished
      . Learn about Macroamylasemia.
      See more Macroamylasemia experts
    View All 11 Distinguished Conditions
    • Advanced
    • Autoimmune Hepatitis
      Dr. Galambos is
      Advanced
      . Learn about Autoimmune Hepatitis.
      See more Autoimmune Hepatitis experts
    • Banti's Syndrome
      Dr. Galambos is
      Advanced
      . Learn about Banti's Syndrome.
      See more Banti's Syndrome experts
    • Cholangitis
      Dr. Galambos is
      Advanced
      . Learn about Cholangitis.
      See more Cholangitis experts
    • Endoscopy
      Dr. Galambos is
      Advanced
      . Learn about Endoscopy.
      See more Endoscopy experts
    • Esophageal Varices
      Dr. Galambos is
      Advanced
      . Learn about Esophageal Varices.
      See more Esophageal Varices experts
    • Gallbladder Disease
      Dr. Galambos is
      Advanced
      . Learn about Gallbladder Disease.
      See more Gallbladder Disease experts
    View All 13 Advanced Conditions
    • Experienced
    • Alpha-1 Antitrypsin Deficiency (AATD)
      Dr. Galambos is
      Experienced
      . Learn about Alpha-1 Antitrypsin Deficiency (AATD).
      See more Alpha-1 Antitrypsin Deficiency (AATD) experts
    • Arteriovenous Malformation
      Dr. Galambos is
      Experienced
      . Learn about Arteriovenous Malformation.
      See more Arteriovenous Malformation experts
    • Caroli Disease
      Dr. Galambos is
      Experienced
      . Learn about Caroli Disease.
      See more Caroli Disease experts
    • Colonoscopy
      Dr. Galambos is
      Experienced
      . Learn about Colonoscopy.
      See more Colonoscopy experts
    • Congenital Hepatic Fibrosis
      Dr. Galambos is
      Experienced
      . Learn about Congenital Hepatic Fibrosis.
      See more Congenital Hepatic Fibrosis experts
    • Fibrolamellar Carcinoma
      Dr. Galambos is
      Experienced
      . Learn about Fibrolamellar Carcinoma.
      See more Fibrolamellar Carcinoma experts
    View All 14 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.